sanofi-aventis, Crucell in rabies deal

Crucell (Euronext:CRXL; NASDAQ:CRXL) granted sanofi-aventis (Euronext:SAN; NYSE:SNY) exclusive worldwide rights outside Europe to distribute Crucell's rabies antibody product for post-exposure prophyl...